Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
PART 1 — Disease Prevention & Health Promotion (5 items)
1) Reference
Ch. 1-02 — Health Maintenance & Disease Prevention.
accessmedicine.mhmedical.com
Question Stem
A 58-year-old man with a 30-pack-year smoking history
presents for routine care. He is asymptomatic and asks which
,screening would most reduce his lung-cancer mortality risk.
Which approach is most appropriate?
A. Order a one-time low-dose chest CT (LDCT) now and no
further screening.
B. Enroll him in annual low-dose chest CT screening while he
remains eligible.
C. Recommend chest radiograph (CXR) annually for the next 5
years.
D. Defer any imaging and advise smoking cessation only.
Correct Answer: B
Rationales
• Correct (B): Annual low-dose chest CT in appropriately
selected high-risk adults reduces lung-cancer mortality and
is the recommended screening strategy while the patient
meets eligibility criteria. CMDT emphasizes risk-based
annual LDCT screening for high-risk smokers.
accessmedicine.mhmedical.com
• A: One-time LDCT is inferior to annual LDCT while the
patient remains within screening eligibility; benefit accrues
from regular screening.
• C: Chest radiograph has poor sensitivity for early lung
cancer and is not recommended for screening.
• D: Smoking cessation is essential but does not substitute
for guideline-recommended screening when the patient is
eligible.
,Teaching Point: Annual LDCT, not CXR, is recommended for
eligible high-risk smokers.
Citation (Simplified APA): Papadakis et al. (2025). CURRENT
Medical Diagnosis & Treatment 2026 (65th Ed.). Ch. 1-02.
accessmedicine.mhmedical.com
2) Reference
Ch. 1-02 — Health Maintenance & Disease Prevention.
accessmedicine.mhmedical.com
Question Stem
A 24-year-old woman planning pregnancy asks about
immunizations. She received an MMR in childhood but is
uncertain about rubella immunity. Which is the best next step?
A. Draw rubella IgG to confirm immunity before pregnancy.
B. Give MMR vaccine now and advise pregnancy immediately.
C. Defer any testing or vaccination until after delivery.
D. Assume childhood MMR confers lifelong immunity; no
testing needed.
Correct Answer: A
Rationales
• Correct (A): Confirming rubella IgG status before
conception is appropriate; if nonimmune, MMR
vaccination should be given and pregnancy deferred for 1
month. CMDT highlights verifying immunity and avoiding
, live vaccines during pregnancy.
accessmedicine.mhmedical.com
• B: Administering MMR prior to conception is correct if
nonimmune, but pregnancy should be deferred for at least
1 month after vaccination. Giving MMR and advising
immediate pregnancy is incorrect.
• C: Deferring testing may miss an opportunity to vaccinate
preconception; testing before pregnancy is recommended.
• D: Some adults lack detectable rubella IgG; routine
confirmation is reasonable for those planning pregnancy.
Teaching Point: Verify rubella IgG preconception; if
nonimmune, give MMR and delay pregnancy ≥1 month.
Citation (Simplified APA): Papadakis et al. (2025). CURRENT
Medical Diagnosis & Treatment 2026 (65th Ed.). Ch. 1-02.
accessmedicine.mhmedical.com
3) Reference
Ch. 1-02 — Health Maintenance & Disease Prevention.
accessmedicine.mhmedical.com
Question Stem
A 46-year-old man with well-controlled hypertension asks about
cardiovascular risk reduction. He has LDL 140 mg/dL, no
diabetes, and 10-year ASCVD risk of 8%. Which intervention will
most directly lower his 10-year ASCVD risk?